DTC drug advertising ethics: laboratory for medical marketing

Author(s):  
Michael Mackert ◽  
Marie Guadagno ◽  
Amanda Mabry ◽  
Lindsay Chilek
1974 ◽  
Vol 4 (3) ◽  
pp. 223-226 ◽  
Author(s):  
Donald L. Kanter

Dr. Kanter presents a summary of his research assessing the role of OTC advertising in Influencing drug usage. His work represents the only systematic study of the impact of commercial advertising on drug usage. He stresses that advertising in itself does not directly lead to drug misuse but should be considered as part of a host of factors in the social environment and in the media environment that have significant influence in determining people's behavior. He also urged that the existing pharmaceutical advertising codes, which are often violated, be reviewed and strengthened.


1999 ◽  
Vol 25 (1) ◽  
pp. 149-167
Author(s):  
Tamar V. Terzian

The Food and Drug Administration (FDA) regulates the promotion of pharmaceutical products. The FDA's regulations issued under the Food, Drug and Cosmetic Act (FDCA) require that prescription drug broadcast advertisements include the following: (1) a major statement of the product's risks in at least the audio part of the advertisement; and (2) that an adequate provision for the dissemination of the approved package labeling be made “in connection with the broadcast presentation,” if the brief summary is not also part of the advertisement. Under the FDCA, the brief summary provides information concerning the major risks of the drug.


2021 ◽  
Vol 35 (1) ◽  
pp. 31-38
Author(s):  
Katherine A. P. Zagrodney ◽  
Natasha Y. Sheikhan ◽  
Ashlyn Pinto ◽  
Tania Sheikhan ◽  
Theodore J. Witek

1980 ◽  
Vol 44 (3) ◽  
pp. 316 ◽  
Author(s):  
John R. Rossiter ◽  
Thomas S. Robertson
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document